Detalles de la búsqueda
1.
Multiple genetic loci influence vaccine-induced protection against Mycobacterium tuberculosis in genetically diverse mice.
PLoS Pathog
; 20(3): e1012069, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38452145
2.
Systems genetics uncover new loci containing functional gene candidates in Mycobacterium tuberculosis-infected Diversity Outbred mice.
PLoS Pathog
; 20(6): e1011915, 2024 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38861581
3.
Intravenous BCG Vaccination of Diversity Outbred Mice Results in Moderately Enhanced Protection against Challenge with Mycobacterium tuberculosis Compared to Intradermal Vaccination.
Infect Immun
; 91(7): e0016823, 2023 07 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37338410
4.
Pigs naturally exposed to porcine circovirus type 2 (PCV2) generate antibody responses capable to neutralise PCV2 isolates of different genotypes and geographic origins.
Vet Res
; 45: 29, 2014 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-24602200
5.
Host Genetic Background Influences BCG-Induced Antibodies Cross-Reactive to SARS-CoV-2 Spike Protein.
Vaccines (Basel)
; 12(3)2024 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38543876
6.
Interleukin-6 is essential for primary resistance to Francisella tularensis live vaccine strain infection.
Infect Immun
; 81(2): 585-97, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23230288
7.
Transcriptional signatures measured in whole blood correlate with protection against tuberculosis in inbred and outbred mice.
PLoS One
; 18(8): e0289358, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37535648
8.
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case.
Vaccine
; 40(12): 1681-1690, 2022 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35164990
9.
Deficiency in CCR2 increases susceptibility of mice to infection with an intracellular pathogen, Francisella tularensis LVS, but does not impair development of protective immunity.
PLoS One
; 16(3): e0249142, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33760886
10.
Whole genome profiling refines a panel of correlates to predict vaccine efficacy against Mycobacterium tuberculosis.
Tuberculosis (Edinb)
; 120: 101895, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32090856
11.
Production of IFN-γ by splenic dendritic cells during innate immune responses against Francisella tularensis LVS depends on MyD88, but not TLR2, TLR4, or TLR9.
PLoS One
; 15(8): e0237034, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32745117
12.
The Diversity Outbred Mouse Population Is an Improved Animal Model of Vaccination against Tuberculosis That Reflects Heterogeneity of Protection.
mSphere
; 5(2)2020 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32295871
13.
The Many Hosts of Mycobacteria 8 (MHM8): A conference report.
Tuberculosis (Edinb)
; 121: 101914, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32279870
14.
Sequence comparison of Francisella tularensis LVS, LVS-G and LVS-R.
Pathog Dis
; 76(7)2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30137434
15.
Progress, challenges, and opportunities in Francisella vaccine development.
Expert Rev Vaccines
; 15(9): 1183-96, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27010448
16.
GM-CSF has disparate roles during intranasal and intradermal Francisella tularensis infection.
Microbes Infect
; 18(12): 758-767, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27475899
17.
Correlates of Vaccine-Induced Protection against Mycobacterium tuberculosis Revealed in Comparative Analyses of Lymphocyte Populations.
Clin Vaccine Immunol
; 22(10): 1096-108, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26269537
18.
IL-23 p19 knockout mice exhibit minimal defects in responses to primary and secondary infection with Francisella tularensis LVS.
PLoS One
; 9(10): e109898, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25296161
19.
Immunogenicity and protective efficacy of novel Mycobacterium tuberculosis antigens.
Vaccine
; 31(41): 4641-6, 2013 Sep 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-23906890
20.
Immunity conferred by an experimental vaccine based on the recombinant PCV2 Cap protein expressed in Trichoplusia ni-larvae.
Vaccine
; 28(11): 2340-9, 2010 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-20056179